Point72 Hong Kong’s CalciMedica CALC Stock Holding History

Point72 Hong Kong’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14	Closed	-$1K	–	1936
2021 Q3	$1K	Sell	14 -236	-94%	-$13.3K	﹤0.01%	1894
2021 Q2	$19K	Buy	+250	New	+$16.4K	﹤0.01%	1651

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Hong Kong's CALC Position: Q4 2021 in Review

Point72 Hong Kong sold out of CalciMedica (CALC) in Q4 2021, closing a stake of 14 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in CALC in Q2 2021 and held it in 2 quarters. The position peaked at $19K in Q2 2021. 28 funds tracked by Wall St. Rank hold CALC as of Q4 2021.

Point72 Hong Kong reported no remaining CalciMedica position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 14 CalciMedica shares in Q4 2021, an estimated $1K.
Point72 Hong Kong first reported a position in CalciMedica in Q2 2021 and held it in 2 quarters.
Point72 Hong Kong's CalciMedica position peaked at $19K in Q2 2021.
28 funds tracked by Wall St. Rank held CalciMedica as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.